Browsing by Yonsei Author : Park, Jun Yong

eperson profile image
Name:
Park, Jun Yong [박준용]
orcid http://orcid.org/0000-0001-6324-2224
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (47861376300)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 405

This table browses all dspace content
Issue DateTitleJournal Title
2023Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models BIOMEDICINE & PHARMACOTHERAPY
2023Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinomaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2023Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis DIAGNOSTICS
2023Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping NATURE COMMUNICATIONS
2022ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related CirrhosisCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinomaLIVER INTERNATIONAL
2022Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner JOURNAL OF HEPATOLOGY
2022Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology Journal of Liver Cancer(대한간암학회지)
2022Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease GUT AND LIVER
2022Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model GASTROENTEROLOGY REPORT
2022Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis BDIGESTIVE DISEASES AND SCIENCES
2022Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) CANCERS
2022Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis CANCERS
2022Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels JOURNAL OF HEPATOLOGY
2022KASL clinical practice guidelines for management of chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2022Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria FRONTIERS IN MEDICINE
2022Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter studyJOURNAL OF VIRAL HEPATITIS
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Impaired antibacterial response of liver sinusoidal Vγ9 + Vδ2 + T cells in patients with chronic liver diseaseGUT
2022Predictors of Sarcopenia in an Obese Asian PopulationNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2022A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling AMERICAN JOURNAL OF CANCER RESEARCH
2022External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study CANCERS
2022Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis DIAGNOSTICS
2022Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mLAMERICAN JOURNAL OF GASTROENTEROLOGY
2022Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitisRHEUMATOLOGY INTERNATIONAL
2022Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents SCIENTIFIC REPORTS
2022Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization CANCERS
2022Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis BJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2022Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients CANCERS
2021Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis BEXPERT OPINION ON PHARMACOTHERAPY
2021Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy CANCERS
2021No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal ActivationHEPATOLOGY
2021Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma AMERICAN JOURNAL OF CANCER RESEARCH
2021Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2021Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis BHEPATOLOGY INTERNATIONAL
2021Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South KoreaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease CANCERS
2021Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapyHEPATOLOGY INTERNATIONAL
2021Pharmacokinetics and safety of evogliptin in hepatically impaired patientsBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2021The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinomaEUROPEAN JOURNAL OF INTERNAL MEDICINE
2021다중유전자 위험점수를 이용한 비알코올 지방간질환에서 간세포암종 발생 예측 모델 Korean Journal of Gastroenterology
2021Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyDIGESTIVE DISEASES AND SCIENCES
2021Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis BEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Browse

Links